Overview

Nesiritide in Resistant Hypertension

Status:
Terminated

Trial end date:
2014-07-01

Target enrollment:

Participant gender:

Summary

Hypothesis: If the use of B-type natriuretic peptide (BNP) is proven to be effective in controlling high blood pressure, it may lead to a reduction of standard therapy and improved cardiovascular and kidney protection.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

John C Burnett
Mayo Clinic

Collaborator:

National Center for Research Resources (NCRR)

Treatments:

Natriuretic Peptide, Brain